Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



IPOs at Any Cost

It's easy to look back on the tech bubble at the turn of the 20th century with a sense of nostalgia. Unlike the greedy financiers of late, the decade preceding Y2K was marked by naive 20-somethings intent on changing the world with a newfangled form of communication called the Internet.

It was a time when dated and musty ideas like revenue, profit, and margins were shunted aside in favor of "stickiness" and "eyeballs." An era when a company like could go public to wide market acclaim even though it lost money on virtually every sale it made and went bankrupt less than a year after its IPO.

Indeed, the late 1990s were truly the heyday of initial public offerings. In the decade prior to 1999, the market averaged 547 IPOs a year. It's averaged 192 since.

Yet underneath the innocence and ingenuity of Silicon Valley, there lay a more sinister force responsible for the artificial inflation of IPOs and the resulting $5 trillion in wealth that evaporated virtually overnight when the tech bubble burst on March 20, 2000.

The Global Analyst Research Settlement
In what came to be known as the Global Analyst Research Settlement of 2003, 10 of the county's biggest financial firms -- including Goldman Sachs (NYSE: GS  ) , JPMorgan Chase (NYSE: JPM  ) , and Citigroup (NYSE: C  ) , among others -- coughed up nearly $900 million for producing misleading and sometimes fraudulent research reports to their retail clients in order to pump up shares and attract IPO underwriting fees from investment banking clients.

"The banks did this," said Eliot Spitzer, the New York Attorney General at the time, "because of the conflicts of interest woven into their business model. They were underwriting the very stocks they were also touting, making the investing public dupes helping the banks generate enormous fees."

The behavior of Piper Jaffray (NYSE: PJC  ) in August of 2000 provides a typical example. That month, the firm's investment bankers made a pitch to underwrite the IPO of a highly speculative medical technology company. Included was a mock research report recommending the stock as a "Strong Buy." After being awarded the desired role, due in part to the pitch, and recording the nearly $4 million in associated fees, research analysts at the investment bank initiated coverage of the company with the promised, and ostensibly independent, "Strong Buy" recommendation. Piper Jaffray even compensated research analysts based on how much revenue the investment bank was earning from the company.

As a result of the settlement, in addition to paying nearly $900 million in fees and disgorgement, at the time a historic amount, the financial firms agreed to physically and operationally separate their research and investment banking departments. Known in the industry as Chinese walls, the purpose was to help ensure that the latter didn't continue to improperly influence the independent judgment of the former.

More recently, it's been reported that Facebook's (Nasdaq: FB  ) underwriters (including Morgan Stanley, JPMorgan, and Goldman Sachs) privately warned some of their favored clients about the company's slowing revenue prospects as they continued to hype its public offering.

IPOs at any cost
The JOBS Act removes many of the investor protections that Wall Street agreed to in the Global Settlement.  While it does so under the auspices of job creation, one must wonder whether boosting IPOs at the likely expense of fraud is really the most effective means to achieve this end. We don't think it is.

Let the SEC know how you feel about the JOBS Act by following this link. Simply tell them you're an individual investor and feel free to share your concerns or suggestions.

Click here to read the final piece in our series: "Our Letter to the SEC."

Fool contributor John Maxfield does not have a financial stake in any of the companies mentioned above. The Motley Fool owns shares of Citigroup and JPMorgan Chase. Motley Fool newsletter services have recommended buying shares of Goldman Sachs. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1925162, ~/Articles/ArticleHandler.aspx, 10/21/2016 7:44:46 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 10 hours ago Sponsored by:
DOW 18,162.35 -40.27 -0.22%
S&P 500 2,141.34 -2.95 -0.14%
NASD 5,241.83 -4.58 -0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/20/2016 4:01 PM
C $49.58 Up +0.10 +0.20%
Citigroup CAPS Rating: ***
FB $130.00 Down -0.11 -0.08%
Facebook CAPS Rating: ***
GS $174.51 Down +0.00 +0.00%
Goldman Sachs CAPS Rating: ***
JPM $68.26 Down -0.09 -0.13%
JPMorgan Chase CAPS Rating: ****
PJC $50.85 Down -0.50 -0.97%
Piper Jaffray Comp… CAPS Rating: No stars